Drug application
BLEOMYCIN SULFATE (BLEOMYCIN SULFATE)
Drugs@FDA ANDA 209439 · CIPLA
Key facts
| Drug name | BLEOMYCIN SULFATE |
|---|---|
| Active ingredients | BLEOMYCIN SULFATE |
| Application type | ANDA |
| Application number | 209439 |
| Company | CIPLA |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 15 UNITS BASE/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Mar 11, 2019 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.